A Study of SGN-STNV in Advanced Solid Tumors

Clinical trial NCT04665921 · TERMINATED

Trial details

NCT number: NCT04665921
Sponsor: Seagen Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma, Non-Small Cell Lung HER2 Negative Breast Neoplasms Ovarian Neoplasms Uterine Cervical Neoplasms Endometrial Neoplasms Esophageal Neoplasms Gastroesophageal Junction Carcinoma Stomach Neoplasms Colorectal Neoplasms Exocrine Pancreatic Adenocarcinoma Appendiceal Adenocarcinoma Pseudomyxoma Peritonei

Start date: 2021-01-18
Primary completion: 2024-03-01
Enrollment: 111

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.